Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
398
datasets available to search
ShareScore release 0.9.0
Dataset results
398 results for “EBVs”
ADjuVant Apatinib in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy
ClinicalTrials.gov study NCT02874651. IPD Sharing: NO. Countries: 1. Publications: 0.
Zanubrutinib Combined With Tislelizumab in the Treatment of r/r PMBCL and EBV+ DLBCL
ClinicalTrials.gov study NCT04705129. IPD Sharing: NO. Countries: 1. Publications: 0.
Relationship Between EBV and PTLD
ClinicalTrials.gov study NCT00215033. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases
ClinicalTrials.gov study NCT01447056. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Trial to Evaluate an EBV-derived Dendritic Cell Vaccine in Autologous Stem Cell Transplant
ClinicalTrials.gov study NCT02115126. IPD Sharing: Not stated. Countries: 1. Publications: 0.
EBV-TCR-T Cells for EB Virus Infection After HSCT
ClinicalTrials.gov study NCT04156217. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Detection of Herpesvirus DNA (CMV, EBV, HHV-6 and HSV) in Colonic Tissue: Impact on Ulcerative Colitis Flare-up
ClinicalTrials.gov study NCT03172195. IPD Sharing: NO. Countries: 1. Publications: 0.
Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells, Relapsed Lymphoma, ANGEL
ClinicalTrials.gov study NCT00058617. IPD Sharing: Not stated. Countries: 1. Publications: 0.
EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ Diseases
ClinicalTrials.gov study NCT05688241. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Epstein-Barr Virus (EBV)-Specific T Cells as Therapy for Relapsed/Refractory EBV-positive Lymphomas
ClinicalTrials.gov study NCT00779337. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Donor-Derived EBV-Specific T Cells for Life Threatening EBV-lymphoma (OLIP-EBV-TCL-01-HMR01)
ClinicalTrials.gov study NCT06391814. IPD Sharing: NO. Countries: 1. Publications: 0.
Treating Severe Chronic Epstein-Barr Virus (EBV) Infection With EBV Specific Cytotoxic T Lymphocytes (CTLs)
ClinicalTrials.gov study NCT00058591. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Improved Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Protocol for the Treatment of Epstein Barr Virus T/NK Lymphoproliferative Disease (EBV-T/NK LPD) and Prevention of Post Transp
ClinicalTrials.gov study NCT07029958. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of the Safety and Efficacy of EBV Specific T-cell Lines
ClinicalTrials.gov study NCT02580539. IPD Sharing: NO. Countries: 1. Publications: 0.
Tislelizumab Combined With Capecitabine for Nasopharyngeal Carcinoma With Residual EBV DNA After Radiotherapy
ClinicalTrials.gov study NCT07067268. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Radiotherapy Alone Versus Concurrent Chemo-radiotherapy for Nasopharyngeal Carcincoma Patients With Undectable EBV DNA After One Cylce Neoadjuvant Chemotherpy
ClinicalTrials.gov study NCT05674305. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma
ClinicalTrials.gov study NCT01948180. IPD Sharing: NO. Countries: 4. Publications: 0.
Effect of the Plasma EBV DNA Change During Chemoradiotherapy in Nasopharyngeal Carcinoma
ClinicalTrials.gov study NCT03087695. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 1 Study of BRG01 in Subjects With Relapsed/Metastatic Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma
ClinicalTrials.gov study NCT05864924. IPD Sharing: NO. Countries: 1. Publications: 0.
VT-EBV-N for Treatment of Severe in EBV Positive Extranodal NK/T Cell Lymphoma Patients
ClinicalTrials.gov study NCT03671850. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.